Acorda Therapeutics Business Finance Contracts & Agreements
45 Contracts & Agreements
- Assignment Agreements (3 contracts)
- Exchange Agreements (1)
- Guaranty Agreements (1)
- Indenture Agreements (3)
- Note Agreements (5)
- Purchase Agreements (7)
- Registration Rights Agreements (3)
- Security Agreements (1)
- Stock Agreements (13)
- Underwriting Agreements (5)
- Warrant Agreements (3)
- Form of stock option certificate under the Acorda Therapeutics 2016 Inducement Plan (Filed With SEC on March 18, 2022)
- Asset Purchase Agreement, dated as of January 12, 2021, between the Registrant and Catalent Pharma Solutions, Inc (Filed With SEC on March 16, 2021)
- Description of Common Stock (Filed With SEC on March 16, 2021)
- Specimen stock certificate evidencing shares of common stock (Filed With SEC on March 16, 2021)
- Description of Common Stock (Filed With SEC on February 28, 2020)
- Indenture, dated as of December 23, 2019, among the Company, the guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent (Filed With SEC on December 26, 2019)
- Registration Rights Agreement, dated as of December 20, 2019, among the Company and the investors party thereto (Filed With SEC on December 26, 2019)
- Security Agreement, dated as of December 23, 2019, from the grantors named therein to Wilmington Trust, National Association, as collateral agent (Filed With SEC on December 26, 2019)
- Form of Exchange Agent Agreement, dated as of December 20, 2019, among the Company, the guarantors party thereto, and the holder named therein (Filed With SEC on December 26, 2019)
- Rights Agreement, dated as of August 31, 2017, between Acorda Therapeutics, Inc. and Computershare Trust Company, N.A, as Rights Agent, which includes the Form of Certificate of... (Filed With SEC on September 1, 2017)
- SECOND AMENDMENT TO ASSET PURCHASE AND LICENSE AGREEMENT (Filed With SEC on February 27, 2015)
- AMENDMENT TO ASSET PURCHASE AND LICENSE AGREEMENT (Filed With SEC on February 27, 2015)
- ASSET PURCHASE AND LICENSE AGREEMENT BY AND BETWEEN ALKERMES, INC. AND CORREGIDOR THERAPEUTICS, INC. DECEMBER 27, 2010 (Filed With SEC on February 27, 2015)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on February 27, 2015)
- ACORDA THERAPEUTICS, INC. 2006 Employee Stock Option Plan Non-Statutory Stock Option Certificate (Filed With SEC on February 27, 2015)
- ACORDA THERAPEUTICS, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTALINDENTURE Dated as of June 23, 2014 to Indenture Dated as ofJune 23, 2014 1.75%... (Filed With SEC on June 23, 2014)
- ACORDA THERAPEUTICS, INC., Company AND WILMINGTON TRUST, NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of June 23, 2014 Senior Debt Securities CROSS-REFERENCE TABLE* (Filed With SEC on June 23, 2014)
- ACORDATHERAPEUTICS, INC. 1.75% Convertible Notes due June 15, 2021 Underwriting Agreement June 17, 2014 (Filed With SEC on June 23, 2014)
- ASSET PURCHASE AGREEMENT by and between ELAN PHARMACEUTICALS, INC. and ACORDA THERAPEUTICS, INC. dated as of July21, 2004 (Filed With SEC on May 9, 2014)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on March 3, 2014)
- Acorda Therapeutics, Inc. 4,000,000 Shares Common Stock UNDERWRITING AGREEMENT dated August 6, 2008 DEUTSCHE BANK SECURITIES INC. (Filed With SEC on August 7, 2008)
- Acorda Therapeutics, Inc. 3,300,000 Shares Common Stock UNDERWRITING AGREEMENT dated February 12,2008 J.P.Morgan Securities Inc. DeutscheBank Securities Inc. (Filed With SEC on February 14, 2008)
- Acorda Therapeutics, Inc. 3,750,000 Shares Common Stock UNDERWRITING AGREEMENT dated June 7, 2007 Banc of America Securities LLC Deutsche Bank Securities Inc. (Filed With SEC on June 8, 2007)
- FIRST AMENDMENT TO REVENUE INTERESTS ASSIGNMENT AGREEMENT AND TO GUARANTY (Filed With SEC on November 29, 2006)
- Acorda Therapeutics, Inc. [] Shares Common Stock UNDERWRITING AGREEMENT dated [], 2006 Banc ofAmerica Securities LLC LazardCapital Markets LLC PiperJaffray & Co. SGCowen & Co., LLC (Filed With SEC on February 3, 2006)
- REVENUE INTERESTS ASSIGNMENT AGREEMENT Dated as of December 23, 2005 between ACORDA THERAPEUTICS, INC. and KING GEORGE HOLDINGS LUXEMBOURG IIA S. R.L. (Filed With SEC on January 5, 2006)
- WARRANT (Filed With SEC on January 5, 2006)
- STOCK WARRANTAGREEMENT To Purchase 40,000Shares of the Common Stock of ACORDATHERAPEUTICS, INC. Dated effective asof May 1, 1996 (Filed With SEC on January 5, 2006)
- WARRANT (Filed With SEC on November 29, 2005)
- PROMISSORY NOTE (Filed With SEC on October 5, 2005)
- ACORDA THERAPEUTICS, INC. FULL RECOURSE CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 5, 2005)
- ACORDATHERAPEUTICS, INC. LIMITEDRECOURSE CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 5, 2005)
- DOMAIN NAME ASSIGNMENT AGREEMENT (Filed With SEC on October 5, 2005)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on October 5, 2005)
- SIXTHAMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 5, 2005)
- AMENDMENT NO. 2 TO 1999 EMPLOYEE STOCK OPTION PLAN (Filed With SEC on October 5, 2005)
- AMENDMENT TO 1999 EMPLOYEE STOCK OPTION PLAN (Filed With SEC on October 5, 2005)
- ACORDATHERAPEUTICS, INC. 1999EMPLOYEE STOCK OPTION PLAN (Filed With SEC on October 5, 2005)
- SECOND CLOSING WARRANT To Purchase Shares of the Series B Preferred Stock of ACORDA THERAPEUTICS, INC. (Filed With SEC on October 5, 2005)
- AcordaTherapeutics, Inc. [___] Shares Common Stock UNDERWRITINGAGREEMENT dated [___], 2003 Banc of America Securities LLC Lazard Frres & Co. LLC (Filed With SEC on November 6, 2003)
